Summary of evidence on comprehensive healthcare for chemotherapy-induced peripheral neuropathy in cancer patients
A partir d'une revue de la littérature (60 articles), cette étude analyse l'efficacité des stratégies de prise en charge d'une neuropathie périphérique induite par la chimiothérapie chez les patients atteints d'un cancer
Objective: This paper aims to provide an evidence-based summary of the most effective strategies for comprehensive healthcare of chemotherapy-induced peripheral neuropathy (CIPN) in cancer patients. Method: Following the “6S” model, relevant evidence on CIPN management was collected from reputable evidence-based resource websites and databases nationally and internationally. The included articles were evaluated for methodological quality, and evidence was extracted using the Australian JBI Evidence-based Health Care Center’s literature evaluation standard (2016 edition). Results: A total of 60 articles were included in this study, comprising 2 guidelines, 5 expert consensus statements, and 53 systematic reviews. The findings of these articles were summarized across 7 dimensions, including risk factor screening, assessment, diagnosis, prevention, treatment, management, and health education, resulting in the identification of 42 relevant pieces of evidence. Conclusions: This study provides a comprehensive synthesis of evidence-based recommendations for managing CIPN in cancer patients, offering guidance for healthcare professionals engaged in clinical practice. However, when implementing these recommendations, it is crucial to consider the individual patient’s clinical circumstances, preferences, and expert judgment, ensuring feasibility and applicability in real-world clinical settings.